Home Tags Halaven

Tag: Halaven

First Patient Dosed in Phase I Dose-escalation Study with MORAb-202

A first patient has been enrolled into a Phase I cancer study of the novel investigational antibody-drug conjugate MORAb-202, being developed by Morphotek, a...

8th World ADC: Morphotek to Present Preclinical Data on MORAb-202

During the upcoming 8th Annual World ADC being held September 20-22, 2017 at the Sheraton San Diego Marina in San Diego, CA, Morphotek®, a...

X